0001104659-19-060127.txt : 20191212 0001104659-19-060127.hdr.sgml : 20191212 20191105172147 ACCESSION NUMBER: 0001104659-19-060127 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20191105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED DNA SCIENCES INC CENTRAL INDEX KEY: 0000744452 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380] IRS NUMBER: 592262718 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 50 HEALTH SCIENCES DRIVE CITY: STONY BROOK STATE: NY ZIP: 11790 BUSINESS PHONE: 631-240-8800 MAIL ADDRESS: STREET 1: 50 HEALTH SCIENCES DRIVE CITY: STONY BROOK STATE: NY ZIP: 11790 FORMER COMPANY: FORMER CONFORMED NAME: PROHEALTH MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 20010504 FORMER COMPANY: FORMER CONFORMED NAME: DCC ACQUISITION CORP DATE OF NAME CHANGE: 19990211 FORMER COMPANY: FORMER CONFORMED NAME: DATALINK CAPITAL CORP/TX/ DATE OF NAME CHANGE: 19980306 CORRESP 1 filename1.htm

Maxim Group LLC

November 5, 2019

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re:

Applied DNA Sciences, Inc. (the “Company”)
Registration Statement on Form S-1, as amended
File Number: 333-233830

Ladies and Gentlemen:

Pursuant to Section 8(a) of the Securities Act of 1933, as amended, and Rule 461 promulgated thereunder, the undersigned, as the representative of the underwriters for the above-captioned proposed offering, join the acceleration request of the Company and hereby request acceleration of the effective date of the above-captioned Registration Statement to 5:00 p.m., Eastern Time, on November 7, 2019, or as soon thereafter as practicable.

The following is supplemental information supplied under Rule 418(a)(7) and Rule 460 under the Securities Act of 1933:

(i)

Date of preliminary prospectus: November 1, 2019

(ii)

Dates of distribution: November 4, 2019 through the date hereof.

(iii)

Number of prospective underwriters and selected dealers to whom the preliminary prospectus was furnished: 12.

(iv)

Number of prospectuses so distributed: 195.

The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating underwriters and dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.

	Sincerely,

	MAXIM GROUP LLC

	By:	/s/ Clifford Teller
	Name:	Clifford Teller
	Title:	Executive Managing Director,
		Head of Investment Banking